Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Going on Trial: Serotonin drug; psilocybin phase 2; placebo response data

Peter Hess

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (6)

  1. Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome. 2023-01-01 · Expand citations
  2. OpenAlex W2099168883
  3. OpenAlex W2887399686
  4. OpenAlex W3179609913
  5. OpenAlex W4362535405
  6. OpenAlex W4365151047

Cited by — these papers cite this paper (0)

No citing papers identified in the available metadata. This does not establish that none exist.